Skip to main content

Enrollment in the Health Benefits for Immigrant Adults (HBIA) program will be temporarily paused effective July 1, 2023.

Enrollment in the Health Benefits for Immigrant Seniors (HBIS) program will be temporarily paused effective Nov. 6, 2023.

Elizabeth M. Whitehorn, Director

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: December 19, 2012

Drug Name Review Type Class Manufacturer
Stribild New Drug Initial Review HIV Gilead
Bydureon New Drug Initial Review Incretin Mimetics � GLP-1 Analog Amylin
Qnasl New Drug Appeal Intranasal Steroid Teva
Pradaxa PDL Appeal Direct Thrombin Inhibitor Boehringer-Ingelheim